Other
Stock options excluded as their inclusion would be anti-dilutive (in shares)
West Pharmaceutical Services Stock options excluded as their inclusion would be anti-dilutive (in shares) remained flat by 0.0% to $400.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.3%, from $300.00K to $400.00K.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026
How to read this metric
A high number suggests that a significant portion of employee options are currently underwater.
Detailed definition
The number of stock options or other equity instruments excluded from the diluted earnings per share calculation because...
Peer comparison
Standard metric for all publicly traded companies with stock option plans.
Metric ID:
other_antidilutive_securities_excluded_from_computation__8368ccHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.00K | $0.00 | $0.00 | $100.00K | $200.00K | $300.00K | $100.00K | $100.00K | $200.00K | $300.00K | $300.00K | $300.00K | $400.00K | $400.00K | $400.00K |
| QoQ Change | — | -100.0% | — | — | +100.0% | +50.0% | -66.7% | +0.0% | +100.0% | +50.0% | +0.0% | +0.0% | +33.3% | +0.0% | +0.0% |
| YoY Change | — | — | — | +0.0% | — | — | +0.0% | -50.0% | -33.3% | +200.0% | +200.0% | +50.0% | +33.3% | +33.3% | +33.3% |
Range$0.00 – $400.00K
CAGR+48.6%
Avg YoY Growth+46.7%
Median YoY Growth+33.3%
Current Streak8 quarters growth
Stock options excluded as their inclusion would be anti-dilutive (in shares) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- West Pharmaceutical Services (WST) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of $400.00K in Q1 2026.
- How has West Pharmaceutical Services's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
- West Pharmaceutical Services's stock options excluded as their inclusion would be anti-dilutive (in shares) increased by 33.3% year-over-year, from $300.00K to $400.00K.
- What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
- Stock options not counted in dilution because they are currently out-of-the-money.